Novel Biologic Agents Targeting Interleukin-23 and Interleukin-17 for Moderate-to-Severe Psoriasis.
about
Novel Biologic Agents Targeting Interleukin-23 and Interleukin-17 for Moderate-to-Severe Psoriasis.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh
2017年學術文章
@zh-hant
name
Novel Biologic Agents Targetin ...... Moderate-to-Severe Psoriasis.
@en
Novel Biologic Agents Targetin ...... Moderate-to-Severe Psoriasis.
@nl
type
label
Novel Biologic Agents Targetin ...... Moderate-to-Severe Psoriasis.
@en
Novel Biologic Agents Targetin ...... Moderate-to-Severe Psoriasis.
@nl
prefLabel
Novel Biologic Agents Targetin ...... Moderate-to-Severe Psoriasis.
@en
Novel Biologic Agents Targetin ...... Moderate-to-Severe Psoriasis.
@nl
P2860
P1476
Novel Biologic Agents Targetin ...... r Moderate-to-Severe Psoriasis
@en
P2093
P2860
P304
P356
10.1007/S40261-017-0550-Z
P50
P577
2017-10-01T00:00:00Z